N-Ethyl-N-3-((3-Dimethylamino-1-Oxo-2-Propenyl)Phenyl)Acetamide CAS:96605-66-2

N-Ethyl-N-3-((3-Dimethylamino-1-Oxo-2-Propenyl)Phenyl)Acetamide

Chemical Name:N-Ethyl-N-3-((3-Dimethylamino-1-Oxo-2-Propenyl)Phenyl)Acetamide
CAS.NO:96605-66-2
Synonyms:N-Ethyl-N-3-((3-Dimethylamino-1-Oxo-2-Propenyl)Phenyl)Acetamide
N-[3-[(E)-3-(dimethylamino)prop-2-enoyl]phenyl]-N-ethylacetamide
N-{3-[(2E)-3-(dimethylamino)prop-2-enoyl]phenyl}-N-ethylacetamide
N-Ethyl-N-[3-[3'-Dimethyl Amino-1'-oxo-2'-Propenyl]phenyl] Acetamide
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 400.7±45.0 °C at 760 mmHg
Molecular Formula C15H20N2O2
Molecular Weight 260.332
Flash Point 168.5±21.1 °C
 
Specification:
Appearance:Yellow crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Zaleplon(CAS:151319-34-5).



We are professional N-Ethyl-N-3-((3-Dimethylamino-1-Oxo-2-Propenyl)Phenyl)Acetamide manufacturer and N-Ethyl-N-[3-[3′-Dimethyl Amino-1′-oxo-2′-Propenyl]phenyl] Acetamide supplier in China, We offer quality N-{3-[(2E)-3-(dimethylamino)prop-2-enoyl]phenyl}-N-ethylacetamide you can fully trust, also we have India factory and producer of N-Ethyl-N-[3-[3′-Dimethyl Amino-1′-oxo-2′-Propenyl]phenyl] Acetamide,Pls send inquiry of N-{3-[(2E)-3-(dimethylamino)prop-2-enoyl]phenyl}-N-ethylacetamide CAS:96605-66-2 to info@nbinno.com if you have any interests, thank you!


Related News: In 2016, in order to promote the innovative development, transformation and upgrading of the pharmaceutical industry, the Development and Reform Commission led the compilation of the “Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry”, which put forward requirements for all aspects of the medical industry and specifically proposed support for the field of chemical raw materials. .2-amino-N-(2-chloro-6-methylphenyl)-1,3-thiazole-5-carboxamide The iLet Bionic Pancreas System is a pocket-sized, wearable investigational medical device that is designed to autonomously control blood-sugar levels.4-Chloro-2-fluorobenzyl bromide CAS:71916-82-0 In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.4-Nitrobenzyl Chloroformate In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California.